Clinical trials
Pathology clinical trials
Below are recruiting pathology clinical trials, each written for real people, not researchers. We’re tracking 297 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07622069Recruiting
Understanding Rare Autoinflammatory Diseases and Their Causes
This study helps doctors better understand rare autoinflammatory diseases—conditions where the immune system mistakenly attacks the body—by collecting information from patients being treated at a major French hospital. Your participation could help improve how these diseases are diagnosed and managed.
LyonAges 4 years+ - NCT07084740Recruiting
Study of blood flow in skin flaps for reconstruction
This study looks at how blood flows through special skin flaps used in reconstructive surgery. It may help doctors better understand and predict how these flaps heal, especially for people who need repair after injuries or pressure sores.
MontpellierAges 18–70 - NCT07098884Recruiting
Using smartphone photos and AI to diagnose lung nodules
This trial uses photos of lung nodule tissue taken with a smartphone and analyzes them with artificial intelligence to improve diagnosis and predict outcomes. It may help people who are scheduled for lung surgery based on CT scans.
Hefei, AnhuiAges 20–75 - NCT07225751Recruiting
MagnetOs Bone Graft vs. Your Own Bone for Foot Fusion
This study tests a new bone graft material (MagnetOs) against using your own bone for hindfoot or ankle fusion surgery. The goal is to see if the new material works just as well for helping bones heal together.
Vail, ColoradoAges 18–75 - NCT06701890Recruiting
Traveler health study
This study follows travelers to learn about illnesses they might get abroad, like infections from mosquitoes or antibiotic-resistant germs. It uses a smartphone app to track your health before, during, and after your trip.
ParisAges 18 years+ - NCT07576608RecruitingPhase 2
New Injectable Treatment for Thick, Raised Scars
This study tests an experimental injection (9MW3811) to help improve the appearance and feel of thick, raised scars that haven't improved on their own in at least 6 months. The treatment may reduce redness, firmness, and other signs of abnormal scarring.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT04815694Recruiting
MRI-guided radiotherapy for rectal cancer
This trial tests whether using MRI scans to guide radiotherapy can improve treatment for people with a certain type of rectal cancer. It focuses on patients whose tumors have not spread to other parts of the body and who have specific tumor features seen on MRI.
Roma, RomaAges 18 years+ - NCT07430579Recruiting
Adebrelimab with chemo for esophageal cancer
This trial tests adding adebrelimab (an immunotherapy drug) to standard chemotherapy for people with a type of esophageal cancer called squamous cell carcinoma. The goal is to see if this combination helps shrink tumors before surgery.
JinanAges 18–80 - NCT06889896Enrolling by invitation
Blood test for Alzheimer's brain changes
This study uses a simple blood test to quickly detect Alzheimer's-related brain changes (amyloid plaques). It may help people with memory concerns avoid a more invasive PET scan and get answers faster.
Hefei, AnhuiAges 45–85 - NCT07374913Recruiting
Study of COL4A1 and COL4A2 gene mutations
This study looks at people with a mutation in the COL4A1 or COL4A2 genes, which can cause problems in small blood vessels throughout the body. It aims to learn more about the condition and may also include family members who carry the mutation or who can serve as healthy controls.
Florence, FIAges Any age - NCT07448584Recruiting
Study of shoulder repair with Lok™ suture anchors
This trial tests how well Lok™ suture anchors work for repairing certain shoulder problems like rotator cuff tears, shoulder instability, or partial tears. It is for people whose MRI confirms the injury and who haven't had prior shoulder surgery on that side.
Valence, Auvergne-Rhône-AlpesAges 18 years+ - NCT06788821Recruiting
Ultrasound study of baby's thyroid in mothers with thyroid issues
This study uses ultrasound to check the baby's thyroid during pregnancy in mothers who have thyroid problems. It aims to see how the thyroid develops and if any extra care is needed.
Bologna, BolognaAges 18–45 - NCT07251582RecruitingPhase 3
Comparing infusion timing for lung cancer immunotherapy before surgery
This trial tests whether the timing of immunotherapy infusion before surgery improves how well the tumor responds in people with stage II to III non-small cell lung cancer. It combines immunotherapy with standard chemotherapy to shrink the tumor before it is removed.
Changsha, HunanAges 18–75 - NCT07239297Enrolling by invitation
Pathology study using existing patient data
This trial reviews stored tissue slides and medical records to build better computer models for diagnosing diseases. No new treatments are tested.
Guangzhou, GuangdongAges 18–75 - NCT06846736Enrolling by invitation
Predicting ALK cancer treatment outcomes using digital pathology
This study uses a computer to analyze digital images of tumor tissue from people with a certain type of lung cancer (ALK-positive non-small cell lung cancer). It aims to see if the computer can predict how well newer-generation ALK inhibitors work in these patients.
Ramat GanAges 18 years+ - NCT06541015Recruiting
TENS for improving walking after stroke
This study tests whether a small electrical device (TENS) can help stroke survivors walk better. You will receive TENS or placebo while walking on a treadmill, and the researchers will measure how your muscles respond.
Dallas, TexasAges 18–80 - NCT07157618Recruiting
Pathology study for patients with slides and records
This trial uses your stored tissue slides and medical history to build a better pathology research tool. It may help future patients get more accurate diagnoses.
Guangzhou, GuangdongAges 18–75 - NCT05905146Recruiting
Personalized opioid plan to shorten treatment time
This trial tests whether a personalized medication plan can help patients with short-term, non-cancer muscle or joint pain need strong opioid medicine for a shorter time. It’s aimed at improving how long treatment lasts while still managing pain.
LilleAges 18 years+ - NCT06280560Recruiting
IVF hormones and womb lining health study
This study looks at how IVF hormone treatments affect the womb lining and whether they cause aging cells to build up. It may help doctors improve IVF success rates.
ValenciaAges 18–45 - NCT06748690Recruiting
Comparing biopsy methods for stomach tumors
This trial compares two ways to take a tissue sample from stomach tumors before surgery to see which works better. The results may help doctors choose the best method for patients.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06764355RecruitingPhase 2
Chemo, Immunotherapy, and Chemoradiation Before Surgery for Advanced Esophageal Cancer
This trial tests a combination of chemotherapy, immunotherapy, and chemoradiation before surgery for people with advanced esophageal squamous cell carcinoma. The goal is to see if this approach helps shrink the tumor and improve outcomes.
TaipeiAges 18–75 - NCT06364371Recruiting
Predicting rectal cancer treatment response using multi-omics
This trial is testing a new way to predict how well your rectal cancer will respond to treatments given before surgery. It uses advanced tests (like looking at genes and other markers) to tailor your care.
Guangzhou, GuangdongAges 18–80 - NCT05812807RecruitingPhase 3
Pembrolizumab versus monitoring after triple-negative breast cancer response
This trial checks whether giving pembrolizumab (an immunotherapy) after surgery helps people with triple-negative breast cancer reduce the chance of the cancer coming back, compared with close monitoring only. It’s for patients who had no remaining invasive cancer after neoadjuvant chemotherapy plus pembrolizumab.
Birmingham, AlabamaAges 18 years+ - NCT06876714RecruitingPhase 3
Shorter vs Longer HER2 Therapy for Breast Cancer with Complete Response
This trial compares 6 months versus 12 months of HER2-targeted therapy for people with HER2+ breast cancer who had a complete response after chemo and trastuzumab. The goal is to see if a shorter treatment is just as effective.
Phoenix, ArizonaAges 18 years+
Hear when a new Pathology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pathology?
- Yes. Clin2 currently lists 297 recruiting pathology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pathology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pathology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.